A Profit Plunge at the Finish Line

The profit figures, reported in late May 2026, came as a shock to many observers because they stood in stark contrast to Unitree's overall growth narrative. In 2025, the company's revenue surged 335% to 1.71 billion yuan, and its humanoid robot business grew from just 1.9% of total revenue in 2023 to more than 51% in the first three quarters of 2025 . Despite that momentum, the Q1 2026 filing showed that adjusted profit fell by more than half compared to the previous year, even as top-line revenue continued to grow .

Sources pointed to a "brutal price war" in the humanoid robot sector and soaring operational expenses as the primary culprits for the margin compression . The development has directly "cast a shadow over its Star Market initial public offering," raising pointed questions among investors about whether Unitree's profitability is structurally sustainable, or if the hyper-competitive market will continue to erode its bottom line .

A Fast-Track IPO That Hasn't Been Derailed—Yet

Despite the sobering financial update, the listing review machinery has continued to accelerate. The Shanghai Stock Exchange's Listing Review Committee will convene on June 1, 2026, to deliberate on Unitree's application—an incredibly fast turnaround of just 73 days since the formal acceptance on March 20, 2026 . The company has already completed two rounds of pre-review inquiry responses and officially disclosed its draft prospectus, demonstrating that regulators are still prioritizing the high-profile listing .

The company is seeking to offer no fewer than 40.4464 million shares, with the proceeds earmarked for strengthening its capital resources and enhancing its end-to-end innovation capabilities in embodied intelligence . No postponement or withdrawal has been announced, signaling that, for now, the IPO's momentum has not been formally disrupted by the profit news .

Ripple Effects Across Mainland Chinese Markets

The news landed with a symbolic thud rather than a market crash. There was no major, broad-based sell-off in mainland Chinese equity markets directly attributed to Unitree's profit plunge . However, the event did draw concentrated attention to valuation risks across the broader robotics sector. Analysts identified ripple effects for related companies, with firms like Shoucheng Holdings being seen as potential beneficiaries or catalysts amid the shifting sentiment .

More broadly, the profit figures have reinforced a cooling of the speculative hype that previously surrounded humanoid-robot stocks. The narrative is shifting from pure growth stories to a more sober assessment of unit economics and competitive dynamics. As one headline aptly put it, "As China's humanoid-robot hype cools, Unitree sees profit plunge" . The development serves as a reality check, encouraging investors to scrutinize whether the sector can cross the chasm from technological marvel to a financially resilient industry.

A Profit Plunge at the Finish Line

The profit figures, reported in late May 2026, came as a shock to many observers because they stood in stark contrast to Unitree's overall growth narrative. In 2025, the company's revenue surged 335% to 1.71 billion yuan, and its humanoid robot business grew from just 1.9% of total revenue in 2023 to more than 51% in the first three quarters of 2025 . Despite that momentum, the Q1 2026 filing showed that adjusted profit fell by more than half compared to the previous year, even as top-line revenue continued to grow .

Sources pointed to a "brutal price war" in the humanoid robot sector and soaring operational expenses as the primary culprits for the margin compression . The development has directly "cast a shadow over its Star Market initial public offering," raising pointed questions among investors about whether Unitree's profitability is structurally sustainable, or if the hyper-competitive market will continue to erode its bottom line .

A Fast-Track IPO That Hasn't Been Derailed—Yet

Despite the sobering financial update, the listing review machinery has continued to accelerate. The Shanghai Stock Exchange's Listing Review Committee will convene on June 1, 2026, to deliberate on Unitree's application—an incredibly fast turnaround of just 73 days since the formal acceptance on March 20, 2026 . The company has already completed two rounds of pre-review inquiry responses and officially disclosed its draft prospectus, demonstrating that regulators are still prioritizing the high-profile listing .

The company is seeking to offer no fewer than 40.4464 million shares, with the proceeds earmarked for strengthening its capital resources and enhancing its end-to-end innovation capabilities in embodied intelligence . No postponement or withdrawal has been announced, signaling that, for now, the IPO's momentum has not been formally disrupted by the profit news .

Ripple Effects Across Mainland Chinese Markets

The news landed with a symbolic thud rather than a market crash. There was no major, broad-based sell-off in mainland Chinese equity markets directly attributed to Unitree's profit plunge . However, the event did draw concentrated attention to valuation risks across the broader robotics sector. Analysts identified ripple effects for related companies, with firms like Shoucheng Holdings being seen as potential beneficiaries or catalysts amid the shifting sentiment .

More broadly, the profit figures have reinforced a cooling of the speculative hype that previously surrounded humanoid-robot stocks. The narrative is shifting from pure growth stories to a more sober assessment of unit economics and competitive dynamics. As one headline aptly put it, "As China's humanoid-robot hype cools, Unitree sees profit plunge" . The development serves as a reality check, encouraging investors to scrutinize whether the sector can cross the chasm from technological marvel to a financially resilient industry.